ALIXO-YOLLOO Files Q3 10-Q, Updates Capital Structure

TL;DR

**ALIXO-YOLLOO's Q3 10-Q is out, check capital changes for financial health.**

AI Summary

ALIXO-YOLLOO CORP. filed its 10-Q for the period ending November 30, 2023, on January 10, 2024. This filing provides an update on the company's financial position and operations for the third quarter of its fiscal year. While specific dollar amounts for revenue or net income are not detailed in the provided snippet, the filing indicates changes in common stock, additional paid-in capital, and retained earnings over various periods, suggesting ongoing financial activity. For investors, understanding these changes is crucial as they reflect the company's capital structure and profitability trends, directly impacting the stock's intrinsic value and future potential.

Why It Matters

This filing provides a snapshot of ALIXO-YOLLOO's financial health, showing how its capital structure and retained earnings have evolved, which is key for assessing its stability and growth prospects.

Risk Assessment

Risk Level: medium — Without specific revenue or profit figures, it's hard to fully assess financial performance, making the investment moderately risky.

Analyst Insight

Investors should review the full 10-Q document for detailed financial statements, especially revenue, net income, and cash flow, to understand the company's performance and make informed decisions, as the provided snippet only offers structural and filing details.

Key Numbers

• 2023-11-30 — Period of Report End Date (Indicates the financial period covered by this 10-Q filing.)
• 2024-01-10 — Filed As Of Date (The date the company officially submitted the 10-Q to the SEC.)
• 0001977837 — Central Index Key (CIK) (Unique identifier for ALIXO-YOLLOO CORP. with the SEC.)
• 333-272825 — SEC File Number (The registration number for the company's securities with the SEC.)
• 37 — Public Document Count (The total number of public documents associated with this filing.)

Key Players & Entities

• ALIXO-YOLLOO CORP. (company) — the company filing the 10-Q
• 0001977837 (company) — Central Index Key (CIK) for ALIXO-YOLLOO CORP.
• November 30, 2023 (date) — the end of the reporting period for the 10-Q
• January 10, 2024 (date) — the date the 10-Q was filed

Forward-Looking Statements

• ALIXO-YOLLOO CORP. will continue to operate in the 'SERVICES-COMPUTER PROCESSING & DATA PREPARATION' sector. (ALIXO-YOLLOO CORP.) — high confidence, target: 2025-01-10

FAQ

Key Financial Figures

• $6,071 — since inception and incurred a loss of $6,071 and $270 for the nine months ended Nove
• $270 — ption and incurred a loss of $6,071 and $270 for the nine months ended November 30,
• $10,142 — resulting in an accumulated deficit of $10,142 as of November 30, 2023 and further los
• $0.001 — 5,000,000 shares of its common stock at $0.001 per share for total proceeds of $5,000
• $5,000 — $0.001 per share for total proceeds of $5,000 to a related party (see NOTE 5). Durin
• $500 — es of common stock for cash proceeds of $500 at $0.02 per share. As of November 30,
• $0.02 — mmon stock for cash proceeds of $500 at $0.02 per share. As of November 30, 2023, th
• $19,970 — Company's operating expenses, of which $19,970 and $0 was advanced during the nine mon
• $0 — perating expenses, of which $19,970 and $0 was advanced during the nine months end
• $17,820 — e Company acquired application code for $17,820 and database for $17,000. During the ni
• $17,000 — ation code for $17,820 and database for $17,000. During the nine months ended November
• $2,168 — reciation expense of software costs was $2,168 and $194 as of November 30, 2023 and Fe
• $194 — xpense of software costs was $2,168 and $194 as of November 30, 2023 and February 28
• $2,130 — et deferred tax assets of approximately $2,130 was not considered more likely than not
• $11,100 — es of common stock for cash proceeds of $11,100 at $0.02 per share. 14 Item 2. Manag

Filing Documents

• alixo_10q30112023.htm (10-Q) — 269KB
• ex31.htm (EX-31.1) — 7KB
• ex32.htm (EX-32.1) — 5KB
• 0001977837-24-000003.txt ( ) — 1453KB
• none-20231130.xsd (EX-101.SCH) — 12KB
• none-20231130_cal.xml (EX-101.CAL) — 11KB
• none-20231130_def.xml (EX-101.DEF) — 14KB
• none-20231130_lab.xml (EX-101.LAB) — 105KB
• none-20231130_pre.xml (EX-101.PRE) — 77KB
• alixo_10q30112023_htm.xml (XML) — 128KB

Financial Statements (Unaudited)

Financial Statements (Unaudited) 5 Condensed Balance Sheets as of November 30, 2023 (Unaudited) and February 28, 2023 6 Condensed Statement of Operations for the three and nine months ended November 30, 2023 and 2022 (Unaudited) 7 8 Condensed Statement of Cash Flows for the nine months ended November 30, 2023 and 2022 (Unaudited) 9 Notes to the Condensed Financial Statements (Unaudited) 10 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 15 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 17 Item 4.

Controls and Procedures

Controls and Procedures 18 PART II OTHER INFORMATION: Item 1.

Legal Proceedings

Legal Proceedings 18 Item 1A

Risk Factors

Risk Factors 18 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 18 Item 3. Defaults Upon Senior Securities 18 Item 4. Mine Safety Disclosures 18 Item 5. Other Information 18 Item 6. Exhibits 19

Signatures

Signatures 19 3 SPECIAL NOTE REGARDING FORWARD—LOOKING STATEMENTS or current facts are forward-looking statements made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933 (the "Act") and Section 21E of the Securities Exchange Act of 1934. These statements often can be identified by the use of terms such as "may", "will", "expect", "believe", "anticipate", "estimate", "approximate" or "continue", or the negative thereof. We intend that such forward-looking in the future. However, forward-looking statements are subject to risks, uncertainties and important factors beyond our control that could cause actual results and events to differ materially from historical results of operations and events and those presently anticipated or projected. We disclaim any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statement or to reflect the occurrence of anticipated or unanticipated events. Financial information contained in this quarterly report and in our unaudited interim financial statements is stated in United States dollars and are prepared in accordance with United 4

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION Item 1.

Financial Statements

Financial Statements The accompanying interim financial statements of Alixo-Yolloo Corporation ("the Company", "we", "us" or our"), have been prepared without audit pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with United States generally accepted principles have been condensed or omitted pursuant to such rules and regulations. The interim financial statements are condensed and should be read in conjunction with the Company's latest annual financial statements. In the opinion of management, the financial statements contain all material adjustments, consisting only of normal adjustments considered necessary to present fairly the financial condition, results of operations, and cash flows of the Company for the interim periods presented. 5 ALIXO-YOLLO CORPORATION BALANCE SHEETS November 30, 2023 (Unaudited) February 28, 2023 ASSETS Current Assets Cash $ 1,337 $ 7,511 Prepaid Expenses - 7,000 Total Current Assets 1,337 14,511 Intangible Assets, Net 39,652 34,626 TOTAL ASSETS $ 40,989 $ 49,137 LIABILITIES & STOCKHOLDER' EQUITY (DEFICIT) Liabilities Current Liabilities Accounts Payable $ 5,988 $ 31,828 Deferred Revenue 3,293 - Related Party Loan 36,350 16,380 Total Current Liabilities 45,631 48,208 Total Liabilities 45,631 48,208 Stockholder' Equity (Deficit) Common Stock, $ 0.001 par value, 75,000,000 shares authorized, 5,025,000 and 5,000,000 shares issued and outstanding as of November 30, 2023 and February 28, 2023, respectively 5,025 5,000 Additional Paid-In Capital 475 - Accumulated Deficit ( 10,142 ) ( 4,071 ) Total Stockholder' Equity (Deficit) ( 4,642 ) 929 TOTAL LIABILITIES & STOCKHOLDER' EQUITY (DEFICIT) $ 40,989 $ 49,137 The accompanying notes are an integral part of these unaudited financial statement

Legal Proceedings

Legal Proceedings As of now, we are not involved in any legal proceedings, and we have not received any information about any upcoming legal actions against us. 15 RESULTS OF OPERATIONS Three months ended November 30, 2023, compared to November 30, 2022 Revenues For the three months ended November 30, 2023 and 2022, the Company generated total revenue of $3,293 having sold the Application Programming Interface (API) packages provided on its website and $0, respectively. Operating expenses Total expenses for the three months ended November 30, 2023 were $3,793 ($90 for the three months ended November 30, 2022) consisting of general and administrative expenses. Expenses increased in the three months ended November 30, 2023 primarily due to the professional fees. Net Losses The company recorded a net income (loss) of $(500) for the three months ended November 30, 2023, and $39 for the three months ended November 30, 2022. Nine months ended November 30, 2023, compared to November 30, 2022 Revenues For the nine months ended November 30, 2023 and 2022, the Company generated total revenue of $18,226 having sold the Application Programming Interface (API) packages provided on its website and $0, respectively. Operating expenses Total expenses for the nine months ended November 30, 2023 were $24,297 ($399 for the nine months ended November 30, 2022) consisting of general and administrative expenses. Expenses increased in the nine months ended November 30, 2023 primarily due to the professional fees. Net Losses The company recorded a net loss of $6,071 for the nine months ended November 30, 2023, and $270 for the nine months ended November 30, 2022. Liquidity and Capital Resources As of November 30, 2023 we have cash reserves of approximately $1,337 and our liabilities are $45,631, comprising $5,988 accounts payable, $3,293 deferred revenue and $36,350 owed to Rassul Sadakbayev, our director. The available capital reserves of the Company are not sufficient

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk Not Applicable. 17 Item 4.

Controls and Procedures

Controls and Procedures Evaluation of Disclosure Controls and Procedures We carried out an evaluation as of November 30, 2023, under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, who are one and the same, of the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(f) and 15d–15(e)). Based upon that evaluation, our principal executive officer and principal financial officer concluded that, as of the end of the period covered in this report, our disclosure controls and procedures were not effective to ensure that information required to be disclosed in reports filed under the Securities Exchang

View Full Filing

View this 10-Q filing on SEC EDGAR